ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
oral contraceptives
The following articles have the tag oral contraceptives
Subdermal contraceptive effective in all body weights
SUBDERMAL implants are just as effective in overweight or obese women and should be offered as a first-line contraceptive regardless of weight, a study suggests.
Contraceptive pill uptake linked to rise in prostate cancer
AN ANALYSIS of the uptake of oral contraceptives (OC) globally has found those countries embracing the pill have seen a rise in prostate cancer incidence.
One in eight young women experience incontinence
A SURVEY of 1000 otherwise healthy young women by researchers at Monash University has found that as many as one in eight experience urinary incontinence. The study, in women aged 16–30 years with an average BMI of 22, provides new information on urinary incontinence by looking at subjects who have never been pregnant, the researchers said. They found 12.6% of the women had urinary incontinence, with 6.2% experiencing stress incontinence, 4.5% experiencing urge incontinence and 1.9% experiencing both. “We found that women are more likely to have incontinence if they ...
Use older OCPs to reduce VTE risk: study
THE safety profile of newer-generation oral contraceptives has been challenged by research showing their use increases the risk of venous thromboembolism (VTE) when compared with older formulations. A retrospective case-control study from the Netherlands showed that lowering the dose of oestrogen, from 30 µg to 20 µg, significantly reduced a premenopausal woman’s risk of VTE. Although all current oral contraceptives increased the risk of venous thrombosis, the risk differed by type of progestogen, as well as by oestrogen dose, and first-generation progestogens conferred a markedly lower VTE risk than did newer products. There was ...
Risks of hormonal contraception in SLE clarified
WHILE many women with systemic lupus erythematosus (SLE) can safely use hormonal contraceptives, experts advise careful consideration of a range of possible risk factors before recommending their use. Researchers from the World Health Organization and the US Centers for Disease Control conducted a systematic review of 13 studies including two randomised controlled trials. The researchers said that in particular women with positive antiphospholipid antibodies were at higher baseline risk of arterial and venous thrombosis and combined hormonal contraception should be avoided. Contraceptive choice for women with SLE should take account of any co-existing medical conditions, such ...